Johnson & Johnson
JNJ: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$979.00 | Mcm | Ltqcrqvx |
Johnson & Johnson's Robust Portfolio and Pipeline Set Up Steady Long-Term Growth
Business Strategy and Outlook
Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that together create a wide economic moat.